CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc.

Bringing life-changing therapeutics to China and the world.

44 employees · est. 1991 · Rockville, United States

VS
Cloudbreak Therapeutics logo

Cloudbreak Therapeutics

Leading the future of eye care with efficient drug repurposing and fast-tracked clinical advancements.

11-50 employees · est. 2015

CASI Pharmaceuticals, Inc. is the older company (1991 vs 2015).

Side-by-Side Comparison

CASI Pharmaceuticals, Inc. Cloudbreak Therapeutics
Founded
1991 older 2015
Headquarters
Rockville, United States Not tracked yet
Employees
44 11-50
Industry
Biotechnology, Pharmaceutical Biotechnology, Health Care
Funding Stage
Post Ipo Equity Series C
Total Funding
Not tracked yet $171.22M
Funding Rounds
10 3
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biopharmaceuticals, Therapeutics Development, Oncology Treatments, Hematology, Drug Commercialization, Global Drug Development, Clinical Stage Drug Candidates, Regulatory Expertise, Acquisitions, Licensing, Drug Portfolio, FDA-approved Drugs, Pharmaceutical Products, Innovative Therapies, China Market Expansion Ocular Drug Development, Clinical-stage Company, Drug Repurposing, Efficient Capital Model, VIC + 505b(2), Proof-of-concept Trials, Contract Research Organizations, Pharmaceutical Development, CMC, Out-licensing, Global Rights, Commercialization, Eye Care, Systemic Drugs
Website
casipharmaceuticals.com cloudbreaktherapeutics.com
CASI Pharmaceuticals, Inc. logo

About CASI Pharmaceuticals, Inc.

CASI Pharmaceuticals, Inc. is a U.S. NASDAQ-listed biopharmaceutical company that focuses on developing and accelerating the launch of innovative therapeutics and pharmaceutical products in China, U.S., and throughout the world. With offices in Rockville, Maryland, and a wholly owned subsidiary in B...

Cloudbreak Therapeutics logo

About Cloudbreak Therapeutics

Cloudbreak Therapeutics is a clinical-stage biotechnology company pioneering the future of eye care through efficient drug repurposing and fast-tracked clinical advancements. Established in 2015, the company focuses on ocular drug development, employing a capital-efficient business model based on VI...

We will tell you when either one moves

BounceWatch watches CASI Pharmaceuticals, Inc. and Cloudbreak Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at CASI Pharmaceuticals,... and Cloudbreak Therapeutic... — by email.

Frequently Asked Questions

CASI Pharmaceuticals, Inc. — Bringing life-changing therapeutics to China and the world.. Cloudbreak Therapeutics — Leading the future of eye care with efficient drug repurposing and fast-tracked clinical advancements.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
CASI Pharmaceuticals, Inc. has raised undisclosed funding while Cloudbreak Therapeutics has raised $171.22M.
CASI Pharmaceuticals, Inc. and Cloudbreak Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare CASI Pharmaceuticals, Inc. with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at CASI Pharmaceuticals, Inc. on 3 Dec 2024, and Cloudbreak Therapeutics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes